Fee-for-service pharmaceutical formulation AI that uses robotics and AI models to develop drug formulations faster than industry standards.
Persist AI provides pharmaceutical formulation development as a service using its own robotic lab and AI models trained on internal experimental data. Customers submit their API and target dosage form and receive formulation reports grounded in literature and regulatory guidance with computational predictions. Example results include nanoparticle development in 28 days vs. 3-6 months industry standard, extended release in 2 weeks vs. 6 months, and peptide half-life extension in 3 months vs. 3 years. Customers own all their data; Persist does not use it to train their AI models. Persist AI is a product of Persist AI.